EUVIMEDEUVIMED entdecken
Crossref

Type 2 statin use increased perioperative blood loss in primary reverse total shoulder arthroplasty

Kotaro Yamakado, Kunihiro Suzuki, Hirofumi Katsutani, Hideaki Nagamoto, Junji Inoue, Hayato Satake, Tsukasa Kumai, Takanori Saito

European Journal of Orthopaedic Surgery & Traumatology · 2025

DOI: 10.1007/s00590-025-04502-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, 2025. Verfasst von Kotaro Yamakado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sports Medicine Center, Kansai Medical University, Hirakata, Japan. yamakadok@gmail.com. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Arthroplasty, Replacement, Shoulder, Postoperative Hemorrhage, Blood Loss, Surgical. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Statins (hydroxyl-methylglutaryl-coenzyme-A reductase inhibitors) are commonly prescribed for managing hypercholesterolemia. Besides lowering cholesterol, statins have been reported to have anticoagulant and antiplatelet effects. This study aimed to analyze postoperative blood loss by standardizing the surgical procedure for reverse total shoulder arthroplasty and evaluate the effect of statin use on bleeding. METHODS: A retrospective review of prospectively collected primary RSA cases was conducted, identifying the use and types of statins: type 1 (naturally derived) and type 2 (synthetic). Those taking anticoagulants and antiplatelet medications were excluded. Multiple regression models were utilized to identify the predictors of estimated blood loss. Blood loss was calculated using preoperative and third-day postoperative hematocrit values. Preoperative factors, surgery-related factors (surgical time, stem length), and the administration of tranexamic acid were collected and analyzed. RESULTS: A total of 243 cases were included. Statins were administered in 62 cases (26%). The estimated blood loss was 826 ± 332 ml in the statin-use group and 738 ± 308 ml in the statin-nonuse group. The regression analysis identified type 2 statin use, male sex, tranexamic acid administration, and ASA classification as statistically significant predictors of total blood loss (P < .05). Specifically, type 2 statin use was associated with an estimated increase in bleeding volume of 148 mL (95% confidence interval: 54 to 242 mL). CONCLUSIONS: The current study showed that type 2 statin use was a significant predictor of increased perioperative blood loss. However, the anticipated increase in bleeding was not significant, and whether the risk of bleeding outweighs the benefits of statin use should be decided on an individual basis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsArthroplasty, Replacement, ShoulderPostoperative HemorrhageBlood Loss, SurgicalHumansMaleFemaleRetrospective StudiesAgedMiddle AgedTranexamic AcidRisk FactorsAntifibrinolytic Agents

Stichwörter der Autor:innen

BleedingComplicationsHyperlipidemiaReverse shoulder arthroplastyStatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsTranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Sports Medicine Center, Kansai Medical University, Hirakata, Japan. yamakadok@gmail.com.
  • Sports Medicine Center, Kansai Medical University, Hirakata, Japan.
  • Department of Orthopaedic Surgery, Kansai Medical University, Hirakata, Japan.
  • Faculty of Sport Sciences, Waseda University, Tokyo, Japan.

Zitieren

APA

Yamakado, K., Suzuki, K., Katsutani, H., Nagamoto, H., Inoue, J., Satake, H., Kumai, T., & Saito, T. (2025). Type 2 statin use increased perioperative blood loss in primary reverse total shoulder arthroplasty. European Journal of Orthopaedic Surgery & Traumatology. https://doi.org/10.1007/s00590-025-04502-2

Vancouver

Yamakado K, Suzuki K, Katsutani H, Nagamoto H, Inoue J, Satake H, et al. Type 2 statin use increased perioperative blood loss in primary reverse total shoulder arthroplasty. European Journal of Orthopaedic Surgery & Traumatology. 2025. doi:10.1007/s00590-025-04502-2

BibTeX
@article{Yamakado2025,
  author = {Yamakado, Kotaro and Suzuki, Kunihiro and Katsutani, Hirofumi and Nagamoto, Hideaki and Inoue, Junji and Satake, Hayato and Kumai, Tsukasa and Saito, Takanori},
  title = {Type 2 statin use increased perioperative blood loss in primary reverse total shoulder arthroplasty},
  journal = {European Journal of Orthopaedic Surgery & Traumatology},
  year = {2025},
  doi = {10.1007/s00590-025-04502-2}
}
Kostenlos starten →